Polyvinylpyrrolidone Assisted One-Pot Synthesis of Size-Tunable Cocktail Nanodrug for Multifunctional Combat of Cancer
DOI: https://doi.org/10.2147/ijn.s459428
IF: 7.033
2024-05-18
International Journal of Nanomedicine
Abstract:Cheng Wang, 1, &ast Jiaoyang Pan, 1, &ast Shaoqing Chen, 2 Lin Qiu, 1 Huaanzi Hu, 1 Li Ji, 3 Jianhao Wang, 1 Wenjia Liu, 4 Xinye Ni 2 1 School of Pharmacy, Changzhou University, Changzhou, Jiangsu Province, People's Republic of China; 2 Department of Radiology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China; 3 Department of Otorhinolaryngology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, People's Republic of China; 4 Department of Gastroenterology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wenjia Liu; Xinye Ni, Email ; Background: The in vivo barriers and multidrug resistance (MDR) are well recognized as great challenges for the fulfillment of antitumor effects of current drugs, which calls for the development of novel therapeutic agents and innovative drug delivery strategies. Nanodrug (ND) combining multiple drugs with distinct modes of action holes the potential to circumvent these challenges, while the introduction of photothermal therapy (PTT) can give further significantly enhanced efficacy in cancer therapy. However, facile preparation of ND which contains dual drugs and photothermal capability with effective cancer treatment ability has rarely been reported. Methods: In this study, we selected curcumin (Cur) and doxorubicin (Dox) as two model drugs for the creation of a cocktail ND (Cur-Dox ND). We utilized polyvinylpyrrolidone (PVP) as a stabilizer and regulator to prepare Cur-Dox ND in a straightforward one-pot method. Results: The size of the resulting Cur-Dox ND can be easily adjusted by tuning the charged ratios. It was noted that both loaded drugs in Cur-Dox ND can realize their functions in the same target cell. Especially, the P-glycoprotein inhibition effect of Cur can synergistically cooperate with Dox, leading to enhanced inhibition of 4T1 cancer cells. Furthermore, Cur-Dox ND exhibited pH-responsive dissociation of loaded drugs and a robust photothermal translation capacity to realize multifunctional combat of cancer for photothermal enhanced anticancer performance. We further demonstrated that this effect can also be realized in 3D multicellular model, which possibly attributed to its superior drug penetration as well as photothermal-enhanced cellular uptake and drug release. Conclusion: In summary, Cur-Dox ND might be a promising ND for better cancer therapy. Keywords: one-pot synthesis, size-tunable, multifunctional, cancer Graphical Cancer, characterized by uncontrolled cell growth and the potential to invade other tissues, poses a profound challenge in the realm of biomedical science and healthcare. 1–3 Cancer remains one of the most formidable diseases worldwide to date, accounting for an estimated 609,820 deaths in the United States alone in 2023. 4 Despite great advances have been achieved in the past decades with the development of various kinds of antitumor drugs, the efficacy of many clinically applied antitumor drugs upon in vivo application is often substantially compromised. 5,6 Recent studies have revealed that in vivo barriers and multidrug resistance (MDR) of cancer cells might contribute significantly to this drawback. 7,8 In vivo barriers encompass the complex physiological environment within living organisms that can impede the effective delivery and distribution of therapeutic agents to target cancer cells. 9 Factors such as the tumor microenvironment, 10 heterogeneous blood supply and drug metabolism, 11 and the presence of physiological barriers like the blood–brain barrier 12 contribute to the intricate landscape that influences drug accessibility and efficacy. Furthermore, MDR, a phenomenon where cancer cells develop resistance to multiple drugs, also poses another significant hurdle. 13 This resistance can arise due to genetic mutations, overexpression of drug efflux pumps, and alterations in cellular signaling pathways. Overcoming these challenges calls for the development of novel therapeutic agents and innovative drug delivery strategies that can evade or overcome these barriers. Drug delivery is the art and science of administering therapeutic agents to specific targets within the body. It involves designing and optimizing delivery systems to ensure precise dosing, targeted delivery, and co -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology